These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Synthesis and biological evaluation of O-alkylated tropolones and related alpha-ketohydroxy derivatives as ribonucleotide reductase inhibitors. Tamburlin-Thumin I; Crozet MP; Barrière JC; Barreau M; Riou JF; Lavelle F Eur J Med Chem; 2001 Jun; 36(6):561-8. PubMed ID: 11525847 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd). Zahedi Avval F; Berndt C; Pramanik A; Holmgren A Biochem Biophys Res Commun; 2009 Feb; 379(3):775-9. PubMed ID: 19121624 [TBL] [Abstract][Full Text] [Related]
12. More potent linear peptide inhibitors of mammalian ribonucleotide reductase. Tan C; Gao Y; Kaur J; Cooperman BS Bioorg Med Chem Lett; 2004 Nov; 14(21):5301-4. PubMed ID: 15454215 [TBL] [Abstract][Full Text] [Related]
13. Ribonucleotide reductase: a critical enzyme for cancer chemotherapy and antiviral agents. Cerqueira NM; Fernandes PA; Ramos MJ Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):11-29. PubMed ID: 18221051 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and ribonucleotide reductase inhibitory activity of analogues of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY). Goddard AJ; Orr RM; Stock JA; Wilman DE Anticancer Drug Des; 1987 Dec; 2(3):235-45. PubMed ID: 3329526 [TBL] [Abstract][Full Text] [Related]
15. Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy. Cerqueira NM; Pereira S; Fernandes PA; Ramos MJ Curr Med Chem; 2005; 12(11):1283-94. PubMed ID: 15974997 [TBL] [Abstract][Full Text] [Related]
16. New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity. Zaltariov MF; Hammerstad M; Arabshahi HJ; Jovanović K; Richter KW; Cazacu M; Shova S; Balan M; Andersen NH; Radulović S; Reynisson J; Andersson KK; Arion VB Inorg Chem; 2017 Mar; 56(6):3532-3549. PubMed ID: 28252952 [TBL] [Abstract][Full Text] [Related]
17. Synthetic nucleosides and nucleotides. 40. Selective inhibition of eukaryotic DNA polymerase alpha by 9-(beta-D-arabinofuranosyl)-2-(p-n-butylanilino) adenine 5'-triphosphate (BuAaraATP) and its 2'-up azido analog: synthesis and enzymatic evaluations. Tomikawa A; Seno M; Sato-Kiyotaki K; Ohtsuki C; Hirai T; Yamaguchi T; Kawaguchi T; Yoshida S; Saneyoshi M Nucleosides Nucleotides; 1998; 17(1-3):487-501. PubMed ID: 9708358 [TBL] [Abstract][Full Text] [Related]
18. Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes. Zídek Z; Potmesil P; Holý A Toxicol Appl Pharmacol; 2003 Nov; 192(3):246-53. PubMed ID: 14575642 [TBL] [Abstract][Full Text] [Related]
19. Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives. Cappellacci L; Franchetti P; Vita P; Petrelli R; Lavecchia A; Jayaram HN; Saiko P; Graser G; Szekeres T; Grifantini M J Med Chem; 2008 Jul; 51(14):4260-9. PubMed ID: 18588281 [TBL] [Abstract][Full Text] [Related]
20. Enantioselectivity of ribonucleotide reductase: a first study using stereoisomers of pyrimidine 2'-azido-2'-deoxynucleosides. Roy B; Verri A; Lossani A; Spadari S; Focher F; Aubertin AM; Gosselin G; Mathé C; Périgaud C Biochem Pharmacol; 2004 Aug; 68(4):711-8. PubMed ID: 15276078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]